跳转至内容
Merck
CN
HomeGet more information on the Viscosity Reduction Platform

Get more information on the Viscosity Reduction Platform

Viscosity reduction platform test kit

The Viscosity Reduction Platform of new excipient combinations enables subcutaneous formulation of highly concentrated protein biologics, bringing together increased concentrations and improved downstream processing.

For feasibility trials at your facilities, we offer a technical sample kit including small scales (100 g) of the following products:

  • 137118 - L-Ornithine monohydrochloride EMPROVE® EXPERT DAB
  • 107267 - L-Phenylalanine EMPROVE® EXPERT Ph Eur, USP
  • 101587 - L-Arginine EMPROVE® EXPERT Ph Eur, ChP, JP, USP
  • 103893 - Benzenesulfonic acid
  • 137156 - Pyridoxine hydrochloride ≥98% (HPLC)
  • 500667 - Thiamine phosphoric acid ester chloride dihydrate EMPROVE® API

Screening the platform for your protein

Submit the form below and one of our technical experts will reach out to you shortly.

Fields indicated by an * are required.

登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?